nitroxoline has been researched along with meropenem in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Brunst, S; Burgers, LD; Frank, D; Fürst, R; Gobec, S; Martinelli, G; Proschak, A; Proschak, E; Rotter, MJ; Sosič, I; Weizel, L; Wichelhaus, TA | 1 |
Fuchs, F; Hamprecht, A | 1 |
Becerra-Aparicio, F; Fuchs, F; Higgins, PG; Seifert, H; Xanthopoulou, K | 1 |
3 other study(ies) available for nitroxoline and meropenem
Article | Year |
---|---|
Nitroxoline and its derivatives are potent inhibitors of metallo-β-lactamases.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Molecular Structure; Nitroquinolines; Recombinant Proteins; Structure-Activity Relationship | 2022 |
Susceptibility of carbapenemase-producing Enterobacterales (CPE) to nitroxoline.
Topics: Anti-Infective Agents, Urinary; Carbapenem-Resistant Enterobacteriaceae; Enterobacter cloacae; Escherichia coli; Humans; Imipenem; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Nitroquinolines | 2019 |
In vitro activity of nitroxoline against carbapenem-resistant Acinetobacter baumannii isolated from the urinary tract.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Ciprofloxacin; Escherichia coli; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Nitroquinolines; Sulfamethoxazole; Trimethoprim; Urinary Tract; Urinary Tract Infections | 2022 |